DK11892D0 - Oxiranderivater og fremgangsmaade til fremstilling deraf - Google Patents

Oxiranderivater og fremgangsmaade til fremstilling deraf

Info

Publication number
DK11892D0
DK11892D0 DK92118A DK11892A DK11892D0 DK 11892 D0 DK11892 D0 DK 11892D0 DK 92118 A DK92118 A DK 92118A DK 11892 A DK11892 A DK 11892A DK 11892 D0 DK11892 D0 DK 11892D0
Authority
DK
Denmark
Prior art keywords
oxirand
procedures
derivatives
preparing
oxirand derivatives
Prior art date
Application number
DK92118A
Other languages
English (en)
Other versions
DK165321C (da
DK165321B (da
DK11892A (da
Inventor
Guy Rosalia Eugene Van Lommen
Marcel Frans Leopold De Bruyn
Marc Francis Josephin Schroven
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK11892D0 publication Critical patent/DK11892D0/da
Publication of DK11892A publication Critical patent/DK11892A/da
Publication of DK165321B publication Critical patent/DK165321B/da
Application granted granted Critical
Publication of DK165321C publication Critical patent/DK165321C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK011892A 1983-12-05 1992-01-31 Oxiranderivater og fremgangsmaade til fremstilling deraf DK165321C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55808183A 1983-12-05 1983-12-05
US55808183 1983-12-05

Publications (4)

Publication Number Publication Date
DK11892D0 true DK11892D0 (da) 1992-01-31
DK11892A DK11892A (da) 1992-01-31
DK165321B DK165321B (da) 1992-11-09
DK165321C DK165321C (da) 1993-03-29

Family

ID=24228139

Family Applications (2)

Application Number Title Priority Date Filing Date
DK577084A DK165112C (da) 1983-12-05 1984-12-04 2,2'-iminobisethanolderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse
DK011892A DK165321C (da) 1983-12-05 1992-01-31 Oxiranderivater og fremgangsmaade til fremstilling deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK577084A DK165112C (da) 1983-12-05 1984-12-04 2,2'-iminobisethanolderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse

Country Status (32)

Country Link
EP (1) EP0145067B1 (da)
JP (1) JPS60132977A (da)
KR (1) KR870000923B1 (da)
AR (1) AR241414A1 (da)
AT (1) ATE40361T1 (da)
AU (1) AU573658B2 (da)
BG (1) BG43866A3 (da)
CA (1) CA1337429C (da)
CS (1) CS250242B2 (da)
CY (1) CY1609A (da)
DD (1) DD235453A5 (da)
DE (1) DE3476388D1 (da)
DK (2) DK165112C (da)
DZ (1) DZ712A1 (da)
ES (1) ES8603870A1 (da)
FI (1) FI82460C (da)
GR (1) GR81098B (da)
HK (1) HK52791A (da)
HU (1) HU202219B (da)
IE (1) IE57831B1 (da)
IL (1) IL73706A (da)
MA (1) MA20292A1 (da)
NO (2) NO169839C (da)
NZ (1) NZ210388A (da)
PH (1) PH22432A (da)
PL (1) PL146342B1 (da)
PT (1) PT79609B (da)
RO (1) RO91184B (da)
SG (1) SG47091G (da)
SU (1) SU1428199A3 (da)
ZA (1) ZA849445B (da)
ZW (1) ZW19784A1 (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337432C (en) * 1988-03-23 1995-10-24 Raymond M. Xhonneux Method of lowering the blood pressure
JPH02103116U (da) * 1989-02-01 1990-08-16
JPH02218675A (ja) * 1989-02-21 1990-08-31 Nippon Kayaku Co Ltd 6―フルオロクロモン―2―カルボン酸及びその製造法
TW199152B (da) * 1990-11-01 1993-02-01 Takeda Pharm Industry Co Ltd
ATE256130T1 (de) * 1993-08-19 2003-12-15 Janssen Pharmaceutica Nv Gefässverengende dihydrobenzopyranderivate
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
ES2169102T3 (es) * 1994-10-14 2002-07-01 Merck Patent Gmbh (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central.
AU733669B2 (en) * 1996-06-07 2001-05-24 Vanderbilt University Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
DK1040106T3 (da) * 1997-12-19 2002-12-02 Bayer Ag Carboxylsubstituerede chromanderivater til anvendelse som beta 3 adrenoreceptor-agonister
US6713651B1 (en) 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
US6362371B1 (en) 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
US6593497B1 (en) 1999-06-02 2003-07-15 Theravance, Inc. β2-adrenergic receptor agonists
US6683115B2 (en) 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
UA73965C2 (en) 1999-12-08 2005-10-17 Theravance Inc b2 ADRENERGIC RECEPTOR ANTAGONISTS
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
ATE437637T1 (de) 2001-05-02 2009-08-15 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
ATE352302T1 (de) 2001-07-26 2007-02-15 Merck Patent Gmbh Verwendung von 2- 5-(4-fluorphenyl)-3- pyridylmethylaminomethyl-chroman und seiner physiologisch annehmbaren salze
US6653323B2 (en) 2001-11-13 2003-11-25 Theravance, Inc. Aryl aniline β2 adrenergic receptor agonists
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
WO2006025070A2 (en) 2004-07-30 2006-03-09 Torrent Pharmaceuticals Limited Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
ES2341250T3 (es) * 2004-08-11 2010-06-17 Hetero Drugs Limited Procedimiento novedoso de preparacion de intermediarios de nebivolol.
CN100341866C (zh) * 2004-08-30 2007-10-10 中国科学院理化技术研究所 α,α’-[亚氨基二(亚甲基)]-双-(6-氟-3,4-二氢-2H-1-苯并吡喃-2-甲醇)甲烷磺酸盐的合成方法
NZ560386A (en) 2005-01-31 2009-12-24 Mylan Lab Inc Pharmaceutical composition comprising hydroxylated nebivolol
WO2006083780A2 (en) * 2005-01-31 2006-08-10 Mylan Laboratories, Inc. Glucuronidated nebivolol
WO2006084684A1 (de) * 2005-02-11 2006-08-17 Stada Arzneimittel Ag Pharmazeutische zusammensetzungen nebivolo und ein hydrophiles polymer
AT502220A1 (de) * 2005-07-19 2007-02-15 Pharmacon Forschung & Beratung Verfahren zur herstellung von nebivolol
RU2392277C2 (ru) * 2005-12-28 2010-06-20 Асино Фарма Аг Способ получения рацемического небиволола
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
US7560575B2 (en) 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
US7858812B2 (en) 2006-01-18 2010-12-28 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
ITMI20061889A1 (it) * 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
PL2099790T3 (pl) 2006-11-27 2010-12-31 Zach System Spa Sposób wytwarzania nebiwololu
US20100137424A1 (en) 2007-01-22 2010-06-03 Mostafa Akbarieh Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
ITMI20080547A1 (it) * 2008-03-31 2009-10-01 Zach System Spa Processo di preparazione di nebivololo
IT1392067B1 (it) * 2008-10-31 2012-02-09 Zach System Spa Processo di preparazione di nebivololo
IT1395354B1 (it) * 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
IT1397962B1 (it) 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
IT1402974B1 (it) 2010-11-30 2013-09-27 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
EP2907809B1 (en) 2014-02-14 2018-08-22 Corden Pharma International GmbH Base-free process for the preparation of ketone intermediates usable for manufacture of nebivolol
EP2907810A1 (en) 2014-02-14 2015-08-19 Corden Pharma International GmbH A new method for producing nebivolol hydrochloride of high purity
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
CN107531662B (zh) 2015-05-19 2021-08-06 浙江奥翔药业股份有限公司 奈必洛尔的合成方法及其中间体化合物
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054655A (da) * 1964-01-24
US4313955A (en) * 1980-10-14 1982-02-02 Ciba-Geigy Corporation 1,5-Bis(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
GB8418472D0 (en) * 1984-07-19 1984-08-22 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
ATE40361T1 (de) 1989-02-15
AU3632684A (en) 1985-06-13
ES538256A0 (es) 1986-01-01
EP0145067B1 (en) 1989-01-25
GR81098B (en) 1984-12-17
DK165112B (da) 1992-10-12
JPH0250114B2 (da) 1990-11-01
ZW19784A1 (en) 1986-07-02
DE3476388D1 (en) 1989-03-02
DK577084D0 (da) 1984-12-04
IL73706A (en) 1988-07-31
KR870000923B1 (ko) 1987-05-07
NZ210388A (en) 1987-07-31
FI82460C (fi) 1991-03-11
HUT37418A (en) 1985-12-28
RO91184A (ro) 1987-07-30
CA1337429C (en) 1995-10-24
FI82460B (fi) 1990-11-30
DK165321C (da) 1993-03-29
ZA849445B (en) 1986-07-30
PT79609B (en) 1986-12-12
EP0145067A3 (en) 1986-03-26
SG47091G (en) 1991-07-26
PL250524A1 (en) 1986-02-25
EP0145067A2 (en) 1985-06-19
IE843103L (en) 1985-06-05
FI844777L (fi) 1985-06-06
HK52791A (en) 1991-07-19
DK165321B (da) 1992-11-09
DK11892A (da) 1992-01-31
NO844845L (no) 1985-06-06
CS250242B2 (en) 1987-04-16
DK165112C (da) 1993-03-01
DD235453A5 (de) 1986-05-07
NO2004007I2 (no) 2005-05-09
PL146342B1 (en) 1989-01-31
NO169839B (no) 1992-05-04
ES8603870A1 (es) 1986-01-01
HU202219B (en) 1991-02-28
PH22432A (en) 1988-09-12
BG43866A3 (en) 1988-08-15
MA20292A1 (fr) 1985-07-01
RO91184B (ro) 1987-07-31
PT79609A (en) 1985-01-01
IL73706A0 (en) 1985-03-31
SU1428199A3 (ru) 1988-09-30
DK577084A (da) 1985-06-06
KR850004485A (ko) 1985-07-15
NO2004007I1 (no) 2004-12-20
AR241414A1 (es) 1992-07-31
NO169839C (no) 1992-08-12
IE57831B1 (en) 1993-04-21
DZ712A1 (fr) 2004-09-13
CY1609A (en) 1992-04-03
JPS60132977A (ja) 1985-07-16
AU573658B2 (en) 1988-06-16
FI844777A0 (fi) 1984-12-04

Similar Documents

Publication Publication Date Title
DK165321C (da) Oxiranderivater og fremgangsmaade til fremstilling deraf
DK493583A (da) Azolderivater og fremgangsmaade til fremstilling deraf
DK99382A (da) Dichlorquinolinderivater og fremgangsmaade til fremstilling heraf
DK566484A (da) Dihydropyridinderivat og fremgangsmaade til fremstilling deraf
DK256485D0 (da) Veterinaert praeparat og fremgangsmaade til fremstilling deraf
DK157683D0 (da) N-phosphonomethylglycinderivater og fremgangsmade til fremstilling og anvendelse deraf
DK572583A (da) Pyridinderivater og fremgangsmaade til fremstilling deraf
DK621484A (da) Acylaminomitosaner og fremgangsmaade til fremstilling deraf
DK343684D0 (da) Phenyletherderivater og fremgangsmaade til fremstilling deraf
DK596784D0 (da) Phenylderivater og fremgangsmaade til fremstilling deraf
DK445784A (da) Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf
DK401385A (da) 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf
DK135684A (da) 2-cyano-imidazopyridin-derivater og fremgangsmaade til fremstilling heraf
DK26384A (da) Toxoplasmosefaktor og fremgangsmaade til fremstilling deraf
DK552284A (da) 2-chlor-3-trifluormethylbenzaldehyd og fremgangsmaade til fremstilling deraf
DK454784D0 (da) 6-oxodecahydroquinoliner og fremgangsmaade til fremstilling heraf
DK454684A (da) 7beta-acylamino-3-azido-cephalosporiner og fremgangsmaade til fremstilling heraf
DK446685A (da) Carbapenemderivater og fremgangsmaade til fremstilling deraf
DK90083A (da) Isoxazolopyrimidinderivater og fremgangsmaade til fremstilling deraf
DK596884D0 (da) Phenylderivater og fremgangsmaade til fremstilling deraf
DK182585D0 (da) Fosfomycinderivat og fremgangsmaade til fremstilling deraf
DK14685A (da) Thioketenderivater og fremgangsmaade til fremstilling deraf
DK284184A (da) 1-phenoxy-3-hydroxyindolylalkylamino-3-propanoler og fremgangsmaade til fremstilling deraf
DK47184D0 (da) Benzazepin-derivater og fremgangsmaade til fremstilling deraf
DK550883D0 (da) Hexahydrodioxopyrimidiner og fremgangsmade til fremstilling deraf

Legal Events

Date Code Title Description
PUP Patent expired